Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Dispensing Study for the Phenacite Project

30. Oktober 2020 aktualisiert von: CooperVision, Inc.

Dispensing Study for the Phenacite Project.

The investigational test lens was not the final optical design and the study was not used for design validation.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Detaillierte Beschreibung

Evaluate the objective and patient-reported visual acceptability of the Phenacite contact lens.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

25

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Indiana
      • Bloomington, Indiana, Vereinigte Staaten, 47405
        • Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 35 Jahre (Erwachsene)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Oculo-visual examination in the last two years
  • Between 18 and 35 years of age and has full legal capacity to volunteer
  • Has read and understood the informed consent letter
  • Is willing and able to follow instructions and maintain the appointment schedule
  • Is correctable to a visual acuity of 20/25 or better (in each eye) with their habitual correction or 20/20 best corrected
  • Currently wears, or has previously successfully worn, soft contact lenses between -1.00D and -4.00D
  • Spherical Contact Lens Rx between -1.00 and -4.00 and spectacle cylinder ≤-0.75
  • Has not worn lenses for at least 12 hours before the initial visit
  • Has a subjective response at baseline, which indicates suitability for this study
  • Currently spends a minimum of 4 hours a day; 5 days a week on digital devices and can replicate this time during the study period
  • Is willing and able to wear the study contact lenses a minimum of 10 hours per day; 5 days a week.

Exclusion Criteria:

  • Has never worn contact lenses before
  • Any systemic disease affecting ocular health
  • Is using any systemic or topical medications that will affect ocular health
  • Has known sensitivity to the diagnostic pharmaceuticals or study products used in this study.
  • Has any ocular pathology or anomaly that would affect the wearing of the lenses
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye
  • Is aphakic
  • Has anisometropia of >1.00
  • Has undergone corneal refractive surgery
  • Has strabismus
  • Has any ocular amblyopia >= 1line of HC Visual Acuity
  • Is participating in any other type of eye related clinical or research study
  • Has participated in study CV-14-32.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Crossover-Aufgabe
  • Maskierung: Doppelt

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Phenacite
Subjects will be randomized to wear the Phenacite contact lenses binocularly.
Subjects will be randomized to wear the Phenacite contact lenses binocularly.
Subjects will be randomized to wear the comfilcon A contact lenses binocularly.
Aktiver Komparator: comfilcon A
Subjects will be randomized to wear the comfilcon A contact lenses binocularly.
Subjects will be randomized to wear the Phenacite contact lenses binocularly.
Subjects will be randomized to wear the comfilcon A contact lenses binocularly.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Subjective Ratings of Lens Comfort
Zeitfenster: Baseline (after 15 minutes of lens dispense)
Subjective ratings of lens comfort. Comfort Scale (0,100; 0=extremely uncomfortable/cannot tolerate; 100 = extremely comfortable/cannot be felt)
Baseline (after 15 minutes of lens dispense)
Subjective Ratings of Lens Comfort
Zeitfenster: 2 Weeks
Subjective ratings of lens comfort. Comfort Scale (0,100; 0=extremely uncomfortable/cannot tolerate; 100 = extremely comfortable/cannot be felt)
2 Weeks
Over Refraction for Optimized Distance Acuity
Zeitfenster: 2 weeks
Over Refraction for optimized distance acuity measured using logMAR
2 weeks
Binocular Distance Visual Acuity - High Illumination High Contrast
Zeitfenster: Baseline (after 5 minutes of lens dispense)
Binocular Distance Visual Acuity - High Illumination High Contrast was measured using logMAR
Baseline (after 5 minutes of lens dispense)
Binocular Distance Visual Acuity - High Illumination High Contrast
Zeitfenster: 2 weeks
Binocular Distance Visual Acuity - High Illumination High Contrast was measured using logMAR
2 weeks
Binocular Distance Visual Acuity - Low Illumination High Contrast
Zeitfenster: Baseline (after 5 minutes of lens dispense)
Binocular Distance Visual Acuity - Low Illumination High Contrast was measured using logMAR
Baseline (after 5 minutes of lens dispense)
Binocular Distance Visual Acuity - Low Illumination High Contrast
Zeitfenster: 2 weeks
Binocular Distance Visual Acuity - Low Illumination High Contrast was measured using logMAR
2 weeks
Binocular Near Visual Acuity - High Illumination High Contrast
Zeitfenster: Baseline (after 5 minutes of lens dispense)
Binocular Near Visual Acuity - High Illumination High Contrast was measured using logMAR
Baseline (after 5 minutes of lens dispense)
Binocular Near Visual Acuity - High Illumination High Contrast
Zeitfenster: 2 weeks
Binocular Near Visual Acuity - High Illumination High Contrast was measured using logMAR
2 weeks
Binocular Near Visual Acuity - Low Illumination High Contrast
Zeitfenster: Baseline (after 5 minutes of lens dispense)
Binocular Near Visual Acuity - Low Illumination High Contrast was measured using logMAR
Baseline (after 5 minutes of lens dispense)
Binocular Near Visual Acuity - Low Illumination High Contrast
Zeitfenster: 2 weeks
Binocular Near Visual Acuity - Low Illumination High Contrast was measured using logMAR
2 weeks

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Lens Fit - Post Blink Movement
Zeitfenster: Baseline (after 15 minutes of lens dispense)
Investigator assessment of Amount of movement (to the nearest 0.1mm) immediately after the blink (0.1mm steps)
Baseline (after 15 minutes of lens dispense)
Lens Fit - Post Blink Movement
Zeitfenster: 2 weeks
Investigator assessment of Amount of movement (to the nearest 0.1mm) immediately after the blink (0.1mm steps)
2 weeks
Push - Up Test for Lens Tightness
Zeitfenster: Baseline (after 15 minutes of lens dispense)
Investigator assessment using Continuous Scale 0-100% (1% steps): 0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement
Baseline (after 15 minutes of lens dispense)
Push - Up Test for Lens Tightness
Zeitfenster: 2 weeks
Investigator assessment using Continuous Scale 0-100% (1% steps): 0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement
2 weeks
Lens Mobility Rating
Zeitfenster: Baseline (after 15 minutes of lens dispense)
Investigator assessment using 5 Categories in 0.50 steps: 0=Immobile - no lag in any versions, 1=Restricted - no lag in some directions but slight lag (0-0.25mm) in others, 2=Secure - slight lag (0.25-0.5mm in each version), 3=Unrestricted - freely lags in a controlled manner on all versions, but not excessive (0.5-1.0mm), 4=Very mobile - excessive lag (>1mm) on versions in all directions in 0.25 steps
Baseline (after 15 minutes of lens dispense)
Lens Mobility Rating
Zeitfenster: 2 weeks
Investigator assessment using 5 Categories in 0.50 steps: 0=Immobile - no lag in any versions, 1=Restricted - no lag in some directions but slight lag (0-0.25mm) in others, 2=Secure - slight lag (0.25-0.5mm in each version), 3=Unrestricted - freely lags in a controlled manner on all versions, but not excessive (0.5-1.0mm), 4=Very mobile - excessive lag (>1mm) on versions in all directions in 0.25 steps
2 weeks
Overall Lens Fit Acceptance
Zeitfenster: Baseline (after 15 minutes of lens dispense)
Investigator assessment using 5 Categories in 0.25 steps: 0=Can't be worn, 1=Poor - should not be dispensed although no immediate danger, 2=Fair, 3=Good, 4=Optimum in 0.25 steps
Baseline (after 15 minutes of lens dispense)
Overall Lens Fit Acceptance
Zeitfenster: 2 weeks
Investigator assessment using 5 Categories in 0.25 steps: 0=Can't be worn, 1=Poor - should not be dispensed although no immediate danger, 2=Fair, 3=Good, 4=Optimum in 0.25 steps
2 weeks
Subjective Ratings for Vision Quality - Distance Vision
Zeitfenster: Baseline (after 15 minutes of lens dispense)
Patient subjective scoring using 0-100 continuous scale for Distance Quality of Vision: 0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time
Baseline (after 15 minutes of lens dispense)
Subjective Ratings for Vision Quality - Distance Vision
Zeitfenster: 2 weeks
Patient subjective scoring using 0-100 continuous scale for Distance Quality of Vision: 0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time
2 weeks
Subjective Ratings for Vision Quality - Near Vision
Zeitfenster: Baseline (after 15 minutes of lens dispense)
Patient subjective scoring using 0-100 continuous scale for Near Quality of Vision: 0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time
Baseline (after 15 minutes of lens dispense)
Subjective Ratings for Vision Quality - Near Vision
Zeitfenster: 2 weeks
Patient subjective scoring using 0-100 continuous scale for Near Quality of Vision: 0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time
2 weeks
Subjective Ratings for Vision Quality - Computer Vision
Zeitfenster: Baseline (after 15 minutes of lens dispense)
Patient subjective scoring using 0-100 continuous scale for Computer Vision: 0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time
Baseline (after 15 minutes of lens dispense)
Subjective Ratings for Vision Quality - Computer Vision
Zeitfenster: 2 weeks
Patient subjective scoring using 0-100 continuous scale for Computer Vision: 0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time
2 weeks
Subjective Ratings for Vision Quality - Overall Vision
Zeitfenster: Baseline (after 15 minutes of lens dispense)
Patient subjective scoring using 0-100 continuous scale for Overall Vision: 0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time
Baseline (after 15 minutes of lens dispense)
Subjective Ratings for Vision Quality - Overall Vision
Zeitfenster: 2 weeks
Patient subjective scoring using 0-100 continuous scale for Overall Vision: 0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time
2 weeks
Corneal Staining Extent
Zeitfenster: 2 weeks
Corneal staining extent was assessed on a scale of 0-4 (0-No Staining, 1 - 1-15% of area, 2- 16-30% of area, 3- 31-45% of area, 4- >45% of area
2 weeks
Conjunctival Staining
Zeitfenster: 2 weeks
Conjunctival staining was assessed on a scale of 0-4, 0.50 steps (0-None, 1 - Minimal diffuse punctuate, 2- Coalescent Punctuate, 3- confluent, 4- Deep confluent
2 weeks

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Pete Kollbaun, OD PhD, CORL Indiana University

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. April 2015

Primärer Abschluss (Tatsächlich)

1. Juli 2015

Studienabschluss (Tatsächlich)

1. Juli 2015

Studienanmeldedaten

Zuerst eingereicht

1. Mai 2015

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

1. Mai 2015

Zuerst gepostet (Schätzen)

6. Mai 2015

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

18. November 2020

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

30. Oktober 2020

Zuletzt verifiziert

1. Oktober 2020

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • CV-15-16

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Ja

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren